行业的见解

在制药行业, approximately 90% of all carbon emissions are generated in the manufacturing phase. The biggest positive impact on carbon emissions the secure cold chain can have is therefore to ensure that every single dose that is manufactured reaches the patient securely and on time.

When shipping vaccines or any other temperature-sensitive medical solution, pharmaceutical companies look for partners that ensure high quality, 这样可以简化处理过程, 并帮助减少二氧化碳排放. While active temperature-controlled solutions meet all those requirements, the general perception is that they are more expensive. That perception sometimes makes pharmaceutical companies choose other, 看似成本更低的替代品, 通常被称为被动解决方案, 没有意识到他们本质上是, 为劣质的解决方案付更多的钱.

各种医学领域的突破性研究, 比如基因编辑, 干细胞技术和再生医学, has led to an increased demand for temperature-controlled transport. 高端, specialized medicine is often produced in low volumes with no backup stock and thus, delivering these sensitive products safely across the globe has become a mounting logistical challenge. Selecting a secure and reliable logistics solution has accordingly become all the more important.

随着敏感药物的增多, how can procurement keep transport costs under control while still adhering to necessary quality requirements?

为了简单起见, procurement is about getting the right products and the right services at the right price. 复杂的拉菲1娱乐登录注册和服务, 然而, the procurement process is more than just buying upfront. 集成, multifaceted systems and services need a strategic approach that is focused on efficiency rather than costs. Temperature-controlled pharmaceutical transport – with its many stakeholders, highly regulated environment and precious products – is precisely such an area that pinpoints the strategic importance of the procurement function. And with the recent development on the market, to procure logistics is not getting any easier.

Mexico has potential for becoming a large exporter of pharmaceuticals, while having an attractive home market for pharmaceutical sales as well. For those who want to take advantage of the rising opportunities in Mexico, there are specific challenges that must be taken into account regarding cold chain transportation of high-quality pharmaceuticals.

Pharma cold chain logistics is very complex with many stakeholders involved. We all work hard to ensure that pharmaceuticals maintain optimal quality all the way to the patients. At 拉菲1娱乐登录注册 we believe that the best way to reach our common goal is to improve collaboration and mutual understanding across the logistics chain, 我们称之为生态系统思维. Here, we share articles with our network that we think could benefit us all.

In this article we present a real-world business case that shows how innovative cold chain solutions can secure transportation at year-end, thereby maximizing long-term profits and improve customer retention for the forwarder.

The pharmaceutical industry has for many years been a prioritized customer for the air freight sector, but the increasing volumes of e-commerce have changed the game, 尤其是在旺季. 现在, pharmaceutical companies face the risk of having their products left on the tarmac due to capacity constraints, while handbags and other luxury goods are shipped with higher-yield express delivery instead.

India is the world’s third largest producer of pharmaceuticals in terms of volume. Low costs of manufacturing as well as government subsidies for biosimilars development makes India attractive for export production, 与许多西印度伙伴关系, and the demand in the US and Europe is expected to sustain a high growth rate over a longer period.